Clinical trial Recruiting at 1 site Interventional Ages 18 to 70 Women only

Therapeutic Education for Pregnant Women Having a First Child with Autism

Official title: Evaluation of a Therapeutic Education Program for Pregnant Women With a First Child Diagnosed With an Autism Spectrum Disorder (ASD)

Run by Assistance Publique - Hôpitaux de Paris · NCT05104112 · Data updated 2026-11-12

This study tests a new therapeutic education program (the MER program) for pregnant women who already have a child with autism to see if it improves how they interact with their baby after birth.

More Child Psychiatry trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexWomen only
Enrollment165 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedMay 13, 2025
Main results expectedMarch 13, 2029
Study endsAugust 13, 2029
Registry record updatedNovember 9, 2026
Trial IDNCT05104112 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women (before 26 weeks of gestation) who already have a child diagnosed with autism, with a second parent available if present, and the newborn at risk for ASD.

Probably not a fit

Participants where the mother has an unstable psychiatric condition, intellectual disability, or language barriers preventing participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial with a stepped-wedge design compares an innovative therapeutic education program for expectant mothers to standard care. Participants are pregnant women who already have a child diagnosed with autism and their newborns at risk for ASD, followed from pregnancy through 10 months after birth. The study measures the impact on mother–infant interaction, using the MACI caregiver non-directiveness score as the primary endpoint. Randomization determines when centers begin the MER program, allowing all centers to eventually train and use the intervention while providing a structured control period. Follow-up collects data during pregnancy and after birth to assess whether early parental education can influence developmental trajectories.

Why it matters

Potential benefit: If successful, the MER program could enhance maternal interaction skills and potentially reduce ASD-related risks in high-risk newborns.

How similar studies have gone: Previous research suggests parental interaction interventions in high-risk infants can influence early trajectories, though this exact approach is being tested in a French multicenter, stepped-wedge design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Mothers of children with a diagnosis of ASD, in pregnancy (before the 26th week of amenorrhea);
* The diagnosis of ASD of the older child has been made, according to the DSM IV-TR or DSM 5 criteria, formalized by a diagnostic evaluation including if possible: the Autism Diagnostic Observation Schedule ADOS, and/or ADI
* Informed consent from mother and sec

Exclusion Criteria:

* Presence of a clearly identified and unstabilized severe psychiatric disorder in the mother (confirmed by medical interview and DIGS questionnaire conducted at the time of the inclusion visit) and/or intellectual disability;
* Engagement in another form of individual therapeutic intervention.
* Refusal of either parent (for child assessment, primary criterion)
* Parents not proficient in French language
* Persons (mother or second parent) under legal protection, guardianship or trusteeship, persons deprived of liberty, under court protection, under psychiatric care, under constraint, admitted to a health or social institution for purposes other than research
* Persons with cognitive disorders or intellectual disabilities

Where it's running

  • Hôpital Robert Debré
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.